Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.
Cytokines are a diverse group of proteins and glycoproteins which have potent and wide-ranging effects on eukaryotic cell function and are now recognized as important mediators of tissue pathology in infectious diseases. It is increasingly recognized that for many bacterial species, cytokine induction is a major virulence mechanism. Until recent years, the only bacterial component known to stimulate cytokine synthesis was lipopolysaccharide (LPS). It is only within the past decade that it has been clearly shown that many components associated with the bacterial cell wall, including proteins, glycoproteins, lipoproteins, carbohydrates, and lipids, have the capacity to stimulate mammalian cells to produce a diverse array of cytokines. It has been established that many of these cytokine-inducing molecules act by mechanisms distinct from that of LPS, and thus their activities are not due to LPS contamination. Bacteria produce a wide range of virulence factors which cause host tissue pathology, and these diverse factors have been grouped into four families: adhesins, aggressins, impedins, and invasins. We suggest that the array of bacterial cytokine-inducing molecules represents a new class of bacterial virulence factor, and, by analogy with the known virulence families, we suggest the term "modulin" to describe these molecules, because the action of cytokines is to modulate eukaryotic cell behavior. This review summarizes our current understanding of cytokine biology in relation to tissue homeostasis and disease and concisely reviews the current literature on the cytokine-inducing molecules produced by gram-negative and gram-positive bacteria, with an emphasis on the cellular mechanisms responsible for cytokine induction. We propose that modulins, by controlling the host immune and inflammatory responses, maintain the large commensal flora that all multicellular organisms support.
Henderson
B
B
Maxillofacial Surgery Research Unit, University College London, United Kingdom. B.Henderson@Eastman.ucl.ac.uk
Poole
S
S
Wilson
M
M
D000818:Animals; D001419:Bacteria / Q000472:pathogenicity*; D001426:Bacterial Proteins / Q000502:physiology*; D016207:Cytokines / Q000096:biosynthesis* / Q000502:physiology; D004731:Endotoxins / Q000502:physiology*; D005098:Exotoxins / Q000502:physiology; D006801:Humans; D008070:Lipopolysaccharides / Q000378:metabolism; D011135:Polysaccharides, Bacterial / Q000502:physiology*; D018089:Superantigens; D013682:Teichoic Acids / Q000378:metabolism; D014774:Virulence
D001426:Bacterial Proteins; D016207:Cytokines; D004731:Endotoxins; D005098:Exotoxins; D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial; D018089:Superantigens; D013682:Teichoic Acids